Loading…
Further studies of tyrosine surrogates in opioid receptor peptide ligands
A series of opioid peptide ligands containing modified N-terminal tyrosine (Tyr) residues was prepared and evaluated against cloned human μ, δ, and κ opioid receptors. This work extends the recent discovery that ( S)-4-carboxamidophenylalanine (Cpa) is an effective tyrosine bioisostere. Amino acids...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2007-05, Vol.17 (9), p.2656-2660 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of opioid peptide ligands containing modified N-terminal tyrosine (Tyr) residues was prepared and evaluated against cloned human μ, δ, and κ opioid receptors. This work extends the recent discovery that (
S)-4-carboxamidophenylalanine (Cpa) is an effective tyrosine bioisostere. Amino acids containing negatively charged functional groups in place of tyrosine’s phenolic hydroxyl lacked receptor affinity, while exchange of Tyr for (
S)-4-aminophenylalanine was modestly successful. Peptides containing the new amino acids, (
S)-4-carboxamido-2,6-dimethylphenylalanine (Cdp) and (
S)-β-(2-aminobenzo[
d]thiazol-6-yl)alanine (Aba), displayed binding (
K
i) and functional (EC
50) profiles comparable to the parent ligands at the three receptors. Cdp represents the best performing Tyr surrogate in terms of overall activity, while Cpa and Aba show a subtle proclivity toward the δ receptor. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2007.01.092 |